Guangshengyuan

Guangdong Guangshengyuan Biotechnology is a clinical-stage biotechnology company headquartered in Guangzhou, China, dedicated to the development of advanced cell-based therapies. The company focuses on two primary pillars: immune cell therapy, including CAR-T and NK cells, and stem cell technology, specifically Umbilical Cord Mesenchymal Stem Cells (UC-MSCs). Guangshengyuan operates the Guangdong Provincial Cell Resource Bank and maintains high-standard GMP manufacturing facilities for cell production and storage. Its clinical pipeline includes programs for liver cirrhosis, osteoarthritis, and various hematological malignancies. The company aims to bridge the gap between basic cell research and clinical application to provide innovative treatments for unmet medical needs. By leveraging its integrated platform for cell storage and R&D, Guangshengyuan is positioned as a key player in the regenerative medicine sector in Southern China.